Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome
Clinical trial NCT07150013 · RECRUITING
Trial details
- NCT number
- NCT07150013
- Sponsor
- Unravel Biosciences, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-15
- Primary completion
- 2026-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.